ID: ALA3629177

Max Phase: Preclinical

Molecular Formula: C26H27N5O5

Molecular Weight: 489.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(Nc2nc3cc(NC(=O)CCCCOc4ccc(/C(N)=N/O)cc4)ccc3o2)cc1

Standard InChI:  InChI=1S/C26H27N5O5/c1-34-20-12-7-18(8-13-20)29-26-30-22-16-19(9-14-23(22)36-26)28-24(32)4-2-3-15-35-21-10-5-17(6-11-21)25(27)31-33/h5-14,16,33H,2-4,15H2,1H3,(H2,27,31)(H,28,32)(H,29,30)

Standard InChI Key:  HFTRNYFARDMCBM-UHFFFAOYSA-N

Associated Targets(non-human)

Arachidonate 5-lipoxygenase 121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Tumor necrosis factor ligand superfamily member 11 83 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 489.53Molecular Weight (Monoisotopic): 489.2012AlogP: 4.86#Rotatable Bonds: 11
Polar Surface Area: 144.23Molecular Species: BASEHBA: 8HBD: 4
#RO5 Violations: 0HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.93CX Basic pKa: 15.00CX LogP: 3.93CX LogD: 3.91
Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.08Np Likeness Score: -1.19

References

1. Kang JH, Ting Z, Moon MR, Sim JS, Lee JM, Doh KE, Hong S, Cui M, Choi S, Chang HW, Park Choo HY, Yim M..  (2015)  5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1 expression.,  23  (21): [PMID:26432605] [10.1016/j.bmc.2015.09.025]

Source